THE ROLE OF LAPATINIB IN THE MANAGEMENT OF HER2-POSITIVE METASTATIC BREAST CANCER: A REVIEW OF A SINGLE INSTITUTION'S EXPERIENCE DURING THE TRASTUZUMAB AND LAPATINIB ERA

Watanabe Junichiro; Matsuo Satomo

首页> 外文期刊>The Breast : >THE ROLE OF LAPATINIB IN THE MANAGEMENT OF HER2-POSITIVE METASTATIC BREAST CANCER: A REVIEW OF A SINGLE INSTITUTION'S EXPERIENCE DURING THE TRASTUZUMAB AND LAPATINIB ERA

【24h】

THE ROLE OF LAPATINIB IN THE MANAGEMENT OF HER2-POSITIVE METASTATIC BREAST CANCER: A REVIEW OF A SINGLE INSTITUTION'S EXPERIENCE DURING THE TRASTUZUMAB AND LAPATINIB ERA

机译：Lapatinib在Her2阳性转移性乳腺癌管理中的作用：在曲妥珠单抗和拉帕替尼时代期间对单一机构的经验进行审查

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Breast :》 |2015年第3期|共1页
作者
Watanabe Junichiro; Matsuo Satomo;
展开▼
作者单位

Shizuoka Canc Ctr Breast Oncol Dept Shizuoka Japan;

Shizuoka Canc Ctr Breast Oncol Dept Shizuoka Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类胸部外科学;
关键词

相似文献

外文文献
中文文献
专利

1. THE ROLE OF LAPATINIB IN THE MANAGEMENT OF HER2-POSITIVE METASTATIC BREAST CANCER: A REVIEW OF A SINGLE INSTITUTION'S EXPERIENCE DURING THE TRASTUZUMAB AND LAPATINIB ERA [J] . Watanabe Junichiro, Matsuo Satomo The Breast : . 2015,第Suppla3期

机译：拉帕替尼在HER2阳性转移性乳腺癌的治疗中的作用：对单个机构在曲妥珠单抗和拉帕替尼时代的经历的回顾
2. THE ROLE OF LAPATINIB IN THE MANAGEMENT OF HER2-POSITIVE METASTATIC BREAST CANCER: A REVIEW OF A SINGLE INSTITUTION'S EXPERIENCE DURING THE TRASTUZUMAB AND LAPATINIB ERA [J] . Watanabe Junichiro, Matsuo Satomo The Breast : . 2015,第Suppla3期

机译：Lapatinib在Her2阳性转移性乳腺癌管理中的作用：在曲妥珠单抗和拉帕替尼时代期间对单一机构的经验进行审查
3. Retreatment with trastuzumab after progression on lapatinib-based therapy in heavily pretreated HER2-positive metastatic breast cancer: a single-institution experience [J] . Carli Paolo, Militello Loredana, Miolo Gian Maria, Tumori. . 2014,第6期

机译：在严重预处理的HER2阳性转移性乳腺癌中以拉帕替尼为基础的治疗进展后用曲妥珠单抗再治疗：单机构经验
4. Elevated WBP2 Expression in HER2-Positive Breast Cancers Correlates with Sensitivity to Trastuzumab-Based Neo-Adjuvant Therapy: A Retrospective and Multicentric Study [C] . Yoon Pin Lim International Molecular Medicine Tri-Conference. . 2019

机译：HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关：回顾性和多中心研究
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme including efficacy in brain metastases – the UK experience [O] . S Sutherland, S Ashley, D Miles, 2010

机译：拉帕替尼和卡培他滨在拉帕替尼扩展治疗方案中治疗HER2阳性转移性乳腺癌的方法包括脑转移的疗效–英国经验
7. Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience [O] . Sutherland, S, Ashley, S, Miles, D, 2010

机译：拉帕替尼和卡培他滨在拉帕替尼扩展治疗方案中治疗HER2阳性转移性乳腺癌的方法，包括脑转移的疗效–英国经验

THE ROLE OF LAPATINIB IN THE MANAGEMENT OF HER2-POSITIVE METASTATIC BREAST CANCER: A REVIEW OF A SINGLE INSTITUTION'S EXPERIENCE DURING THE TRASTUZUMAB AND LAPATINIB ERA

著录项

相似文献

相关主题

期刊订阅